Varespladib SodiumProduct ingredient for Varespladib
- Name
- Varespladib Sodium
- Drug Entry
- Varespladib
Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome.
- Accession Number
- DBSALT002103
- Structure
Structure for Varespladib Sodium (DBSALT002103)
- Synonyms
- Not Available
- UNII
- F6M52CDT0W
- CAS Number
- 172733-42-5
- Weight
- Average: 402.382
Monoisotopic: 402.119166 - Chemical Formula
- C21H19N2NaO5
- InChI Key
- XZZUHXILQXLTGV-UHFFFAOYSA-M
- InChI
- InChI=1S/C21H20N2O5.Na/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13;/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25);/q;+1/p-1
- IUPAC Name
- sodium 2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetate
- SMILES
- [Na+].CCC1=C(C(=O)C(N)=O)C2=C(OCC([O-])=O)C=CC=C2N1CC1=CC=CC=C1
- External Links
- ChemSpider
- 137249
- ChEMBL
- CHEMBL2107809
- Predicted Properties
Property Value Source Water Solubility 0.00593 mg/mL ALOGPS logP 3.15 ALOGPS logP 2.77 Chemaxon logS -4.8 ALOGPS pKa (Strongest Acidic) 3.63 Chemaxon pKa (Strongest Basic) -3.7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 114.45 Å2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 113.73 m3·mol-1 Chemaxon Polarizability 38.33 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon